Xtl Biopharmaceuticals (XTLB) EBIT Margin (2011 - 2024)
Xtl Biopharmaceuticals (XTLB) recorded EBIT Margin of 202.42% in the quarter ended Dec 31, 2024.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) EBIT Margin (2011 - 2024) Analysis & Trends
For the year ended Dec 31, 2024, Xtl Biopharmaceuticals reported EBIT Margin of -171.84%.
- Annual EBIT Margin has a four-year change of +8446.34 percentage points (years ended Dec 2020 to Dec 2024).
- Across earlier years, EBIT Margin came in at -8618.18% in the year ended Dec 31, 2020.
- The figure for the quarter ended Dec 31, 2024 is the highest quarterly EBIT Margin in data going back to the quarter ended Jun 30, 2011.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,154.76 Bn | 1,123.35 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 624.99 Bn | 543.52 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 513.90 Bn | 487.02 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 366.41 Bn | 320.79 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 297.87 Bn | 261.86 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 261.73 Bn | 235.41 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 235.10 Bn | 190.50 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 194.01 Bn | 168.20 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 172.33 Bn | 118.98 Bn | 10.94 Bn | 28.37% |
| 10 | Xtl Biopharmaceuticals | 18.55 Mn | 15.35 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 202.42% |
| Sep 30, 2024 | -362.09% |
| Mar 31, 2024 | -26.52% |
| Mar 31, 2022 | -32.98% |
| Dec 31, 2021 | -12.01% |
| Mar 31, 2021 | -44.79% |
| Mar 31, 2020 | -59.77% |
| Mar 31, 2019 | -4.89% |
| Dec 31, 2018 | -21.11% |
| Sep 30, 2018 | -18.45% |
| Jun 30, 2018 | -541.18% |
| Mar 31, 2018 | -22.63% |
| Dec 31, 2017 | -14,300.00% |
| Jun 30, 2017 | -31.92% |
| Mar 31, 2017 | -33.47% |
| Sep 30, 2016 | -2,142.86% |
| Mar 31, 2016 | -2,408.00% |
| Dec 31, 2015 | -1,062.16% |
| Jun 30, 2015 | -890.74% |
| Sep 30, 2014 | -127.87% |
API Access
Xtl Biopharmaceuticals EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();